Blair Jackson
Directeur Financier/CFO chez ALKERMES PLC
Fortune : 4 M $ au 30/06/2024
Profil
Blair C. Jackson est membre du conseil d'administration d'Alkermes Pharma Ireland Ltd. et directeur des opérations et vice-président exécutif d'Alkermes Plc. Dans sa carrière précédente, M. Jackson était vice-président du développement commercial pour Alkermes, Inc. M. Jackson est titulaire d'un diplôme de premier cycle de l'université de Calgary, d'un MBA et d'un diplôme de premier cycle de l'université d'Alberta et d'un diplôme d'études supérieures du Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/02/2024 | 157 802 ( 0,09% ) | 4 M $ | 30/06/2024 |
Postes actifs de Blair Jackson
| Sociétés | Poste | Début |
|---|---|---|
| ALKERMES PLC | Directeur Financier/CFO | 01/02/2024 |
Alkermes Pharma Ireland Ltd.
 Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Directeur/Membre du Conseil | - |
Synchronicity Pharma, Inc.
 Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Directeur/Membre du Conseil | 01/10/2018 |
Anciens postes connus de Blair Jackson
| Sociétés | Poste | Fin |
|---|---|---|
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Directeur/Membre du Conseil | 01/01/2015 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formation de Blair Jackson
| University of Calgary | Undergraduate Degree |
| University of Alberta | Masters Business Admin |
| Massachusetts Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
Alkermes Pharma Ireland Ltd.
Alkermes Pharma Ireland Ltd. Pharmaceuticals: MajorHealth Technology Part of Alkermes Plc, Alkermes Pharma Ireland Ltd. is an Irish pharmaceutical company that specializes in developing medicines for addiction, schizophrenia, bipolar I disorder, neurological disorders, and cancer. The company is based in Athlone, Ireland. The company uses a proven R&D approach to develop treatments in the areas of neuroscience and oncology that address real-world, unmet patient needs. | Health Technology |
Synchronicity Pharma, Inc.
Synchronicity Pharma, Inc. Pharmaceuticals: OtherHealth Technology Synchronicity Pharma, Inc. discovers, develops and commercializes novel therapeutics. Its products identify components of the circadian system that can be targeted to treat metabolic and related disorders, such as diabetes, obesity, and cardiovascular diseases. The company was founded by Ross S. Bersot, Joseph S. Takahashi, Masashi Yanagisawas and Ron Evans in 2008 and is headquartered in San Jose, CA. | Health Technology |
